Trevi Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.About TRVI
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease.
CEOJennifer L. Good
CEOJennifer L. Good
Employees26
Employees26
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2011
Founded2011
Employees26
Employees26
TRVI Key Statistics
Market cap660.83M
Market cap660.83M
Price-Earnings ratio-14.47
Price-Earnings ratio-14.47
Dividend yield—
Dividend yield—
Average volume1.07M
Average volume1.07M
High today$6.64
High today$6.64
Low today$6.43
Low today$6.43
Open price$6.52
Open price$6.52
Volume418.91K
Volume418.91K
52 Week high$7.39
52 Week high$7.39
52 Week low$2.30
52 Week low$2.30
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TRVI. This list is generated using Robinhood data, and it’s not a recommendation.